Stephen P. Ackland
Newcastle, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
A predictive model for life-threatening fluoropyrimidine toxicity based on DPYD sequencing in colorectal cancer.
Journal: Journal of the National Cancer Institute
Published: August 25, 2025
DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol.
Journal: BMC cancer
Published: September 03, 2024
Implementing DPYD genotyping to predict chemotherapy toxicity in Australia: a feasibility study.
Journal: Internal medicine journal
Published: August 06, 2024
Feasibility and population exposure of 5-fluorouracil using therapeutic drug monitoring (PREDICT-5FU): A multicentre clinical trial.
Journal: British journal of clinical pharmacology
Published: July 03, 2024
Evaluation of early fluoropyrimidine toxicity in solid organ cancer patients: a retrospective observational study in Australia.
Journal: Internal medicine journal
Published: February 19, 2024
Commentary: The pharmacogenomic landscape of an Indigenous Australian population.
Journal: Frontiers in pharmacology
Published: January 19, 2024
Risk factors, histopathological landscape, biomarkers, treatment patterns and survival of early-onset colorectal cancer: A narrative review.
Journal: Asia-Pacific journal of clinical oncology
Published: November 14, 2023
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.
Journal: British journal of cancer
Published: July 12, 2023
ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial.
Journal: ESMO gastrointestinal oncology
Published: July 09, 2023
The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology.
Journal: BMC health services research
Published: April 20, 2023
Reply to "Implementation of DPYD Genotyping in Admixed American Populations: Brazil as a Model Case".
Journal: Clinical pharmacology and therapeutics
Published: April 18, 2023
Pharmacogenomics in the era of personalised medicine.
Journal: The Medical journal of Australia
Published: May 05, 2022
Last Updated: 09/26/2026